High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Iovance Biotherapeutics (NASDAQ:IOVA) said it is expanding its tumor-infiltrating lymphocyte, or TIL, therapy platform across multiple solid-tumor indications after reporting a record second quarter marked by nearly $100 million in revenue and a 56% margin. Speaking at the H.C. Wainwright 28th Annu
On September 17, Ferrari N.V. (NYSE:RACE) announced a partnership with the technology company Rakuten Group, Inc., effective January 1, 2027. The announcement gives no scope and no price tag, so it works better as a signal than as a number. The real substance sits in the results Ferrari posted on July 30, when it raised […]
Squatters took over several abandoned Brewdog pubs after the company collapsed, administrators said.
Outsize Social Security raises come with a silver lining for tens of millions of retirees, but also the potential for serious consequences.
On August 20, Royal Caribbean Group (NYSE:RCL) said it had completed a sale of $1.25 billion of notes that carry a 5.55% coupon and come due on January 20, 2034. The money is earmarked first for floating-rate term loans, with anything left over used to repay or refinance other debt, and the offering rode on […]
How does $20,000-plus in annual dividend income sound?
Warren Buffett became the world’s most famous investor by betting on the boring stuff.
On August 6, Wheaton Precious Metals (NYSE:WPM) reported second-quarter net earnings of $543 million on $929 million of revenue, both records. Through the first half, net earnings rose 106% to $1.1 billion. During the quarter, the company also made net upfront cash payments of $4.5 billion relative to mineral stream interests, and it now carries […]
Will one great product make AeroVironment stock a great investment?
Given the number of American seniors who live on Social Security alone, it's important to know where to turn for help.
The agent economy is not being enabled by software; it is being bottlenecked by hardware. While the popular imagination fixates on autonomous code orchestrating value, the actual mechanism of the current market is far more terrestrial. If you cannot power it, you cannot run it. This is the governing rule of the AI era, and […]
Ascendis Pharma (NasdaqGS:ASND) has regained exclusive rights to TransCon technology-based products in metabolic and cardiovascular diseases after ending its collaboration with Novo Nordisk. The company plans to advance its own programs in obesity and type 2 diabetes using its TransCon platform. Management highlighted once-monthly TransCon Semaglutide as a planned program within its expanded metabolic disease pipeline. The regained TransCon metabolic and cardiovascular rights and plans for...
Rafal Brzoska built InPost into a parcel company in nine countries. But it wasn’t always a smooth ride.
Enterprise Products Partners has proven the durability of its high-yielding distribution over the years.
Key TakeawaysBitcoin Rebound: MARA stock jumped 14% Friday as bitcoin surged near $81,000. Split Verdict: Six buys, two outperforms, four holds, one underperform and one sell make up the 14 analysts TIKR tracks on MARA stock, whose mean target of $18 sits 39% above Friday’s close.
The once-high-flying fintech stock has cratered, and investors are wondering what they should do.
New tech, new governance policies, and new revenue sources are helping these coins get on to the path to recovery.
Blackstone (BX) is back in focus after reports that Brookfield Corporation is in advanced talks to buy PGP Glass for about $1.3b to $1.5b, a deal that could potentially give Blackstone a full exit from the investment. Recent price action shows that momentum around Blackstone has cooled. The stock is down 13.87% based on the 30-day share price return, and year to date the share price return has declined 21.31%. The 1-year total shareholder return is down 30.70%, compared with a 23.64% total...
Nike (NKE) just made a high profile boardroom move. The athletic giant expanded its board to twelve directors and added Alexandre Arnault from LVMH, even as it works through a difficult business reset. NIKE’s boardroom refresh comes at a challenging time, with the share price at US$35.51 after falling about 13.5% over the past 30 days and dropping 43.9% year to date. The 1 year total shareholder return is down 48.3% and the 5 year total shareholder return has declined 74.0%, pointing to...
Trade Desk’s healthcare data push Trade Desk (TTD) is back in focus after expanding its integrations with healthcare data specialists Veeva Systems and IQVIA, giving pharma advertisers more granular campaign insights directly inside its advertising platform. Recent trading has been rough for Trade Desk, with the share price down 24.8% over the past 90 days and the year-to-date share price return declining 63.1%, while the 1-year total shareholder return is down 68.7%. This points to fading...
Who gets to qualify as the 1% in Georgia? It's people who meet an annual income threshold, according to SmartAsset, and it's less than you think.
Investing.com -- Artificial intelligence infrastructure has become a politically charged issue ahead of the November U.S. midterm elections, but growing opposition to data centers has yet to materially weaken the construction pipeline, according to Citi.
The assessment isn't a permanent indictment. Indeed, if anything, it's a clarion call.
The skincare brand skipped celebrity endorsements and Sephora shelves, building its business inside dermatologists’ offices and med spas.
These two S&P 500 ETFs seem interchangeable. They're not.
Investors often worry about competition in the chip market.
The e-commerce specialist turned a decade of merchant growth into a roughly 31-fold return. But would I buy the stock today?
NVR (NVR) has drawn attention after recent share price weakness, with the stock down 24% over the past year and about 16% lower year to date as of the last close. That recent weakness comes on top of a broader loss of momentum, with NVR’s share price down 15.5% year to date and the 1-year total shareholder return declining 24.0%, even though the 5-year total shareholder return remains positive at 24.2%. Scan for homebuilders and related consumer durables that may not have seen the same...
Accenture plc (NYSE:ACN) investors are having a rough year, with the shares down more than 25%. Now Wall Street is divided over the company’s outlook. Morgan Stanley raised its price target on Accenture to $175 from $130 on September 14. Accenture shares soared more than 6% in afternoon trading following the price target increase, even […]
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
